Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection

Thorax

Volumn 51, Issue 3, 1996, Pages 312-314

  Kubo, Keishi ^a   Yamaguchi, Shinji ^a   Fujimoto, Keisaku ^a   Hanaoka, Masayuki ^a   Hayasaka, Muneharu ^a   Honda, Takayuki ^a   Sodeyama, Takeshi ^a   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alveolitis; Bronchoalveolar lavage; Hepatitis C virus; Idiopathic pulmonary fibrosis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LUNG ALVEOLITIS; LUNG LAVAGE; LYMPHOCYTE; MALE; PRIORITY JOURNAL;

EID: 0029866881     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.3.312     Document Type: Article

References (14)

1. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung disease of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984;310:154-66.
2. Geist LJ, Hunninghake GW. Potential role of viruses in the pathogenesis of pulmonary fibrosis. Chest 1993;103: 119-20S.
3. Choo Q-L, Kuo G, Weiner AJ, Overvy LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
4. Giusti G, Pasquale G, Galante D, Russo M, Sardaro C, Gallo C, et al. Clinical and histological aspects of chronic HCV infection and cirrhosis. Hepatogastroenterology 1993; 40:365-9.
5. Ueda T, Ohta K, Suzuki M, Yamaguchi M, Hirai K, Horiuchi T, et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992;146:266-8.
6. Irving WL, Day S, Johnston IDA. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis 1993;148:1683-4.
7. Thornthwaite JT, Seckinger D, Rosenthal P, Vazquez A. Characteristics of monoclonal antibody measurements in human peripheral blood. Ann N Y Acad Sci 1986;468: 144-59.
8. The BAL Cooperative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990;141:S169-202.
9. Pham BN, Mosnier JF, Walker F, Njapoum C, Bougy F, Degott C, et al. Flow cytometry CD4+/CD8+ ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B. Clin Exp Immunol 1994;97:403-10.
10. Noguchi H, Kephart GM, Colby TV, Gleich GJ. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol 1992;140:521-8.
11. Peterson MW, Monik M, Hunnighake GW. Prognostic role of eosinophils m pulmonary fibrosis. Chest 1987;92:51-6.
12. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergane D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 1990;335:754-7.
13. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 1991;14:381-8.
14. Chemello L, Albert A, Rose K, Simmonds P. Hepatitis C serotype and response to interferon therapy. N Engl J Med 1994;330:143.